MDDaiichi Sankyo Pharma Development, Basking Ridge, New Jersey, United StatesBasking Ridge, New Jersey, United States
OC 64.5 - Risk of on-treatment recurrent venous thromboembolism in patients with active vs cured cancer patients: a post-hoc analysis of Hokusai VTE cancer
Tuesday, June 27, 202315:45 – 16:00 ET
